[HTML][HTML] Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

C Gao, J Jiang, Y Tan, S Chen - Signal transduction and targeted …, 2023 - nature.com
Microglia activation is observed in various neurodegenerative diseases. Recent advances in
single-cell technologies have revealed that these reactive microglia were with high spatial …

[HTML][HTML] Inflammation in Parkinson's disease: mechanisms and therapeutic implications

M Pajares, A I. Rojo, G Manda, L Boscá, A Cuadrado - Cells, 2020 - mdpi.com
Parkinson's disease (PD) is a common neurodegenerative disorder primarily characterized
by the death of dopaminergic neurons that project from the substantia nigra pars compacta …

[HTML][HTML] Global trends in the incidence, prevalence, and years lived with disability of Parkinson's disease in 204 countries/territories from 1990 to 2019

Z Ou, J Pan, S Tang, D Duan, D Yu, H Nong… - Frontiers in public …, 2021 - frontiersin.org
Background: Parkinson's disease (PD) is an increasing challenge to public health. Tracking
the temporal trends of PD burden would inform health strategies. Methods: Data of PD …

[HTML][HTML] Melatonin and health: insights of melatonin action, biological functions, and associated disorders

SB Ahmad, A Ali, M Bilal, SM Rashid, AB Wani… - Cellular and Molecular …, 2023 - Springer
Melatonin is ubiquitous molecule with wide distribution in nature and is produced by many
living organisms. In human beings, pineal gland is the major site for melatonin production …

[HTML][HTML] Long-term effects of PM2· 5 on neurological disorders in the American Medicare population: a longitudinal cohort study

L Shi, X Wu, MD Yazdi, D Braun, YA Awad… - The Lancet Planetary …, 2020 - thelancet.com
Background Accumulating evidence links fine particulate matter (PM 2· 5) to premature
mortality, cardiovascular disease, and respiratory disease. However, less is known about the …

[HTML][HTML] Historical perspective: models of Parkinson's disease

SJ Chia, EK Tan, YX Chao - International journal of molecular sciences, 2020 - mdpi.com
Parkinson's disease (PD) is the most common movement disorder with motor and nonmotor
signs. The current therapeutic regimen for PD is mainly symptomatic as the etio …

The epidemiology of Parkinson's disease: risk factors and prevention

A Ascherio, MA Schwarzschild - The Lancet Neurology, 2016 - thelancet.com
Since 2006, several longitudinal studies have assessed environmental or behavioural
factors that seem to modify the risk of developing Parkinson's disease. Increased risk of …

[HTML][HTML] The SH-SY5Y cell line in Parkinson's disease research: a systematic review

H Xicoy, B Wieringa, GJM Martens - Molecular neurodegeneration, 2017 - Springer
Parkinson's disease (PD) is a devastating and highly prevalent neurodegenerative disease
for which only symptomatic treatment is available. In order to develop a truly effective …

Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study

H Chen, JC Kwong, R Copes, K Tu, PJ Villeneuve… - The Lancet, 2017 - thelancet.com
Background Emerging evidence suggests that living near major roads might adversely affect
cognition. However, little is known about its relationship with the incidence of dementia …

Long-term effects of exercise and physical therapy in people with Parkinson disease

MK Mak, IS Wong-Yu, X Shen, CL Chung - Nature Reviews Neurology, 2017 - nature.com
Parkinson disease (PD) is a progressive, neurodegenerative movement disorder with
symptoms reflecting various impairments and functional limitations, such as postural …